Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine versus dobutamine for low systemic blood flow in very preterm infants
ACTRN12607000152426Phase 3Completed
- Sponsor
- A/Prof Nick Evans
- Start
- Oct 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dopamine and dobutamine in Shock (2 arms), sponsored by A/Prof Nick Evans. Primary endpoint: Change in systemic blood flow. Started Oct 1998; status: completed.
02
Drugs
dopaminedobutamine
03
Conditions
Shock
Beyond the preview
Go deeper on ACTRN12607000152426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000152426.